세계의 전장 엑솜 시퀀싱(WES) 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Persistence Market Research has recently released a comprehensive report on the worldwide market for whole exome sequencing (WES). The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global whole exome sequencing market from 2025 to 2032.

Key Insights:

• Whole Exome Sequencing Market Size (2025E): USD 2,173.5 Million
• Projected Market Value (2032F): USD 6,879.6 Million
• Global Market Growth Rate (CAGR 2025 to 2032): 17.9%

Whole Exome Sequencing Market - Report Scope:

Whole exome sequencing plays a crucial role in the study of genetic diseases, providing valuable insights into disease mechanisms and potential treatments. The WES market caters to hospitals, research institutions, academic laboratories, and clinical settings, offering a range of sequencing services and solutions. Market growth is driven by advancements in sequencing technologies, decreasing costs, and an increasing demand for precision medicine, genetic testing, and personalized healthcare.

Market Growth Drivers:

The global whole exome sequencing market is propelled by several key factors, including the rising prevalence of genetic disorders and the growing demand for personalized medicine. The increasing focus on genomic research, advancements in sequencing technologies like next-generation sequencing (NGS), and decreasing costs of sequencing are further fueling market expansion. Additionally, the use of WES in cancer research, rare disease diagnosis, and drug development contributes to the growing adoption of exome sequencing services. Moreover, the increased government funding and the expansion of genetic testing platforms provide new opportunities for market players.

Market Restraints:

Despite promising growth prospects, the whole exome sequencing market faces challenges related to high costs, ethical concerns, and regulatory hurdles. The complexity of data analysis and the interpretation of results can be significant barriers to widespread adoption, particularly in resource-limited settings. Additionally, issues around data privacy, patient consent, and the ethical implications of genetic testing present ongoing challenges for stakeholders. The market also faces challenges in terms of the integration of genomic data into clinical practice, requiring collaboration among healthcare providers, policymakers, and researchers.

Market Opportunities:

The whole exome sequencing market presents significant growth opportunities driven by the integration of artificial intelligence (AI) in genomic data analysis, expanding research in rare genetic diseases, and the growing demand for personalized treatment strategies. The development of portable and cost-effective sequencing devices and platforms for point-of-care testing is expected to create new avenues for market players. Furthermore, the increasing focus on companion diagnostics and the development of targeted therapies based on genomic data will drive demand for whole exome sequencing services.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the whole exome sequencing market globally?
• How are advancements in sequencing technologies shaping the adoption of whole exome sequencing?
• What are the major applications of WES across healthcare and research settings?
• Who are the key players contributing to the whole exome sequencing market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global whole exome sequencing market?

Competitive Intelligence and Business Strategy:

Leading players in the global whole exome sequencing market, including Illumina, Thermo Fisher Scientific, and Agilent Technologies, focus on innovation, product differentiation, and strategic collaborations to maintain a competitive edge. These companies invest in research and development to advance sequencing technologies, improve accuracy, and lower sequencing costs. Collaborations with academic institutions, healthcare providers, and biotechnology companies facilitate market access and promote the adoption of WES technologies. Additionally, the emphasis on personalized medicine and targeted therapies drives further research and investment into the WES market.

Key Companies Profiled:

• CD Genomics
• Eurofins Genomics
• GENEWIZ (Azenta Life Sciences)
• Illumina, Inc.
• Integrated DNA Technologies, Inc.
• Blueprint Genetics Oy
• Caris Life Sciences
• MedGenome
• Psomagen
• 3billion, Inc.
• BGI
• Mapmygenome
• Almac Group
• CeGaT GmbH
• Novogene Co., Ltd
• ONEOMICS
• Celemics, Inc.
• Dreamgenics, S.L.
• Gene by Gene, Ltd
• VERITAS INTERCONTINENTAL
• Laboratory Corporation of America(R) Holdings
• Revvity
• Thermo Fisher Scientific Inc.

Whole Exome Sequencing Market Research Segmentation:

The whole exome sequencing market encompasses a diverse range of products, technologies, applications, and end-user segments, addressing various healthcare needs and research fields.

By Product:

• Instruments
• Consumables
• Software and Services

By Application:

• Drug Discovery & Development
• Clinical Diagnostics
• Personalized Medicines
• Others

By Technology:

• ION Semiconductor Sequencing
• Sequencing by Synthesis
• Others

By End-User:

• Hospitals & Diagnostic Laboratories
• Pharma & Biotech Companies
• Contract Research Organizations (CROs)
• Academic and Research Institutes
• Others

By Region:

• North America
• Europe
• East Asia
• South Asia and Oceania
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Whole Exome Sequencing Market Snapshot, 2025 and 2032
• 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global Sectorial Outlook
  • 2.3.2. Global GDP Growth Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Product Adoption Analysis
• 3.2. Regulatory Landscape
• 3.3. Porter's Five Forces Analysis
• 3.4. PESTLE Analysis
• 3.5. Promotional Strategies, By Key Players

4. Price Analysis, 2025A

• 4.1. Key Highlights
• 4.2. Key Factors Impacting Product Prices
• 4.3. Pricing Analysis, By Product
• 4.4. Regional Prices and Product Preferences

5. Global Whole Exome Sequencing Market Outlook

• 5.1. Key Highlights
  • 5.1.1. Market Volume (Units) Projections
  • 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
  • 5.1.3. Absolute $ Opportunity
• 5.2. Market Size (US$ Mn) Analysis and Forecast
  • 5.2.1. Historical Market Size (US$ Mn) and Volume (Units) Analysis, 2019-2024
  • 5.2.2. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, 2025-2032
• 5.3. Global Whole Exome Sequencing Market Outlook: Product
  • 5.3.1. Introduction / Key Findings
  • 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019-2024
  • 5.3.3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 5.3.3.1. Instruments
    • 5.3.3.2. Consumables
    • 5.3.3.3. Software & Services
  • 5.3.4. Market Attractiveness Analysis: Product
• 5.4. Global Whole Exome Sequencing Market Outlook: Application
  • 5.4.1. Introduction / Key Findings
  • 5.4.2. Historical Market Size (US$ Mn), By Application, 2019-2024
  • 5.4.3. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 5.4.3.1. Drug Discovery & Development
    • 5.4.3.2. Clinical Diagnostics
    • 5.4.3.3. Personalized Medicines
    • 5.4.3.4. Others
  • 5.4.4. Market Attractiveness Analysis: Application
• 5.5. Global Whole Exome Sequencing Market Outlook: Technology
  • 5.5.1. Introduction / Key Findings
  • 5.5.2. Historical Market Size (US$ Mn), By Technology, 2019-2024
  • 5.5.3. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 5.5.3.1. ION Semiconductor Sequencing
    • 5.5.3.2. Sequencing by Synthesis
    • 5.5.3.3. Others
  • 5.5.4. Market Attractiveness Analysis: Technology
• 5.6. Global Whole Exome Sequencing Market Outlook: End User
  • 5.6.1. Introduction / Key Findings
  • 5.6.2. Historical Market Size (US$ Mn), By End User, 2019-2024
  • 5.6.3. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 5.6.3.1. Hospitals & Diagnostic Laboratories
    • 5.6.3.2. Pharma & Biotech Companies
    • 5.6.3.3. Contract Research Organizations (CROs)
    • 5.6.3.4. Academic and Research Institutions
    • 5.6.3.5. Others
  • 5.6.4. Market Attractiveness Analysis: End User

6. Global Whole Exome Sequencing Market Outlook: Region

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
• 6.3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
  • 6.3.1. North America
  • 6.3.2. Europe
  • 6.3.3. East Asia
  • 6.3.4. South Asia and Oceania
  • 6.3.5. Latin America
  • 6.3.6. Middle East & Africa
• 6.4. Market Attractiveness Analysis: Region

7. North America Whole Exome Sequencing Market Outlook

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 7.2.1. By Country
  • 7.2.2. By Product
  • 7.2.3. By Application
  • 7.2.4. By Technology
  • 7.2.5. By End User
• 7.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 7.3.1. U.S.
  • 7.3.2. Canada
• 7.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 7.4.1. Instruments
  • 7.4.2. Consumables
  • 7.4.3. Software & Services
• 7.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 7.5.1. Drug Discovery & Development
  • 7.5.2. Clinical Diagnostics
  • 7.5.3. Personalized Medicines
  • 7.5.4. Others
• 7.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
  • 7.6.1. ION Semiconductor Sequencing
  • 7.6.2. Sequencing by Synthesis
  • 7.6.3. Others
• 7.7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 7.7.1. Hospitals & Diagnostic Laboratories
  • 7.7.2. Pharma & Biotech Companies
  • 7.7.3. Contract Research Organizations (CROs)
  • 7.7.4. Academic and Research Institutions
  • 7.7.5. Others
• 7.8. Market Attractiveness Analysis

8. Europe Whole Exome Sequencing Market Outlook

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 8.2.1. By Country
  • 8.2.2. By Product
  • 8.2.3. By Application
  • 8.2.4. By Technology
  • 8.2.5. By End User
• 8.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 8.3.1. Germany
  • 8.3.2. France
  • 8.3.3. U.K.
  • 8.3.4. Italy
  • 8.3.5. Spain
  • 8.3.6. Russia
  • 8.3.7. Turkey
  • 8.3.8. Rest of Europe
• 8.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 8.4.1. Instruments
  • 8.4.2. Consumables
  • 8.4.3. Software & Services
• 8.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 8.5.1. Drug Discovery & Development
  • 8.5.2. Clinical Diagnostics
  • 8.5.3. Personalized Medicines
  • 8.5.4. Others
• 8.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
  • 8.6.1. ION Semiconductor Sequencing
  • 8.6.2. Sequencing by Synthesis
  • 8.6.3. Others
• 8.7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 8.7.1. Hospitals & Diagnostic Laboratories
  • 8.7.2. Pharma & Biotech Companies
  • 8.7.3. Contract Research Organizations (CROs)
  • 8.7.4. Academic and Research Institutions
  • 8.7.5. Others
• 8.8. Market Attractiveness Analysis

9. East Asia Whole Exome Sequencing Market Outlook

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 9.2.1. By Country
  • 9.2.2. By Product
  • 9.2.3. By Application
  • 9.2.4. By Technology
  • 9.2.5. By End User
• 9.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. South Korea
• 9.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 9.4.1. Instruments
  • 9.4.2. Consumables
  • 9.4.3. Software & Services
• 9.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 9.5.1. Drug Discovery & Development
  • 9.5.2. Clinical Diagnostics
  • 9.5.3. Personalized Medicines
  • 9.5.4. Others
• 9.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
  • 9.6.1. ION Semiconductor Sequencing
  • 9.6.2. Sequencing by Synthesis
  • 9.6.3. Others
• 9.7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 9.7.1. Hospitals & Diagnostic Laboratories
  • 9.7.2. Pharma & Biotech Companies
  • 9.7.3. Contract Research Organizations (CROs)
  • 9.7.4. Academic and Research Institutions
  • 9.7.5. Others
• 9.8. Market Attractiveness Analysis

10. South Asia & Oceania Whole Exome Sequencing Market Outlook

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 10.2.1. By Country
  • 10.2.2. By Product
  • 10.2.3. By Application
  • 10.2.4. By Technology
  • 10.2.5. By End User
• 10.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 10.3.1. India
  • 10.3.2. Southeast Asia
  • 10.3.3. ANZ
  • 10.3.4. Rest of South Asia & Oceania
• 10.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 10.4.1. Instruments
  • 10.4.2. Consumables
  • 10.4.3. Software & Services
• 10.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 10.5.1. Drug Discovery & Development
  • 10.5.2. Clinical Diagnostics
  • 10.5.3. Personalized Medicines
  • 10.5.4. Others
• 10.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
  • 10.6.1. ION Semiconductor Sequencing
  • 10.6.2. Sequencing by Synthesis
  • 10.6.3. Others
• 10.7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 10.7.1. Hospitals & Diagnostic Laboratories
  • 10.7.2. Pharma & Biotech Companies
  • 10.7.3. Contract Research Organizations (CROs)
  • 10.7.4. Academic and Research Institutions
  • 10.7.5. Others
• 10.8. Market Attractiveness Analysis

11. Latin America Whole Exome Sequencing Market Outlook

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 11.2.1. By Country
  • 11.2.2. By Product
  • 11.2.3. By Application
  • 11.2.4. By Technology
  • 11.2.5. By End User
• 11.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 11.3.1. Brazil
  • 11.3.2. Mexico
  • 11.3.3. Rest of Latin America
• 11.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 11.4.1. Instruments
  • 11.4.2. Consumables
  • 11.4.3. Software & Services
• 11.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 11.5.1. Drug Discovery & Development
  • 11.5.2. Clinical Diagnostics
  • 11.5.3. Personalized Medicines
  • 11.5.4. Others
• 11.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
  • 11.6.1. ION Semiconductor Sequencing
  • 11.6.2. Sequencing by Synthesis
  • 11.6.3. Others
• 11.7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 11.7.1. Hospitals & Diagnostic Laboratories
  • 11.7.2. Pharma & Biotech Companies
  • 11.7.3. Contract Research Organizations (CROs)
  • 11.7.4. Academic and Research Institutions
  • 11.7.5. Others
• 11.8. Market Attractiveness Analysis

12. Middle East & Africa Whole Exome Sequencing Market Outlook

• 12.1. Key Highlights
• 12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 12.2.1. By Country
  • 12.2.2. By Product
  • 12.2.3. By Application
  • 12.2.4. By Technology
  • 12.2.5. By End User
• 12.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 12.3.1. GCC Countries
  • 12.3.2. Egypt
  • 12.3.3. South Africa
  • 12.3.4. Northern Africa
  • 12.3.5. Rest of Middle East & Africa
• 12.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 12.4.1. Instruments
  • 12.4.2. Consumables
  • 12.4.3. Software & Services
• 12.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 12.5.1. Drug Discovery & Development
  • 12.5.2. Clinical Diagnostics
  • 12.5.3. Personalized Medicines
  • 12.5.4. Others
• 12.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
  • 12.6.1. ION Semiconductor Sequencing
  • 12.6.2. Sequencing by Synthesis
  • 12.6.3. Others
• 12.7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 12.7.1. Hospitals & Diagnostic Laboratories
  • 12.7.2. Pharma & Biotech Companies
  • 12.7.3. Contract Research Organizations (CROs)
  • 12.7.4. Academic and Research Institutions
  • 12.7.5. Others
• 12.8. Market Attractiveness Analysis

13. Competition Landscape

• 13.1. Market Share Analysis, 2025
• 13.2. Market Structure
  • 13.2.1. Competition Intensity Mapping By Market
  • 13.2.2. Competition Dashboard
• 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 13.3.1. CD Genomics
    • 13.3.1.1. Overview
    • 13.3.1.2. Segments and Products
    • 13.3.1.3. Key Financials
    • 13.3.1.4. Market Developments
    • 13.3.1.5. Market Strategy
  • 13.3.2. Eurofins Genomics
  • 13.3.3. GENEWIZ (Azenta Life Sciences)
  • 13.3.4. Illumina, Inc.
  • 13.3.5. Integrated DNA Technologies, Inc.
  • 13.3.6. Blueprint Genetics Oy
  • 13.3.7. Caris Life Sciences
  • 13.3.8. MedGenome
  • 13.3.9. Psomagen
  • 13.3.10. 3billion, Inc.
  • 13.3.11. BGI
  • 13.3.12. Mapmygenome
  • 13.3.13. Almac Group
  • 13.3.14. CeGaT GmbH
  • 13.3.15. Novogene Co., Ltd
  • 13.3.16. ONEOMICS
  • 13.3.17. Celemics, Inc.
  • 13.3.18. Dreamgenics, S.L.
  • 13.3.19. Gene by Gene, Ltd
  • 13.3.20. VERITAS INTERCONTINENTAL
  • 13.3.21. Laboratory Corporation of America(R) Holdings
  • 13.3.22. Revvity
  • 13.3.23. Thermo Fisher Scientific Inc.

14. Appendix

• 14.1. Research Methodology
• 14.2. Research Assumptions
• 14.3. Acronyms and Abbreviations